These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21233533)

  • 1. Therapeutic targeting of HCV internal ribosomal entry site RNA.
    Davis DR; Seth PP
    Antivir Chem Chemother; 2011; 21(3):117-28. PubMed ID: 21233533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R; Ramamurthy SS; Das S
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
    Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S
    Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
    Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
    Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C IRES: translating translation into a therapeutic target.
    Jubin R
    Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication.
    Romero-López C; Berzal-Herranz B; Gómez J; Berzal-Herranz A
    Antiviral Res; 2012 May; 94(2):131-8. PubMed ID: 22426470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
    Paek KY; Kim CS; Park SM; Kim JH; Jang SK
    J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site.
    Kanda T; Zhang B; Kusov Y; Yokosuka O; Gauss-Müller V
    Biochem Biophys Res Commun; 2005 May; 330(4):1217-23. PubMed ID: 15823573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP L is required for the translation mediated by HCV IRES.
    Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
    Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of the IRES of hepatitis C virus RNA to the 40S ribosomal subunit: role of protein p40].
    Malygin AA; Bochkaeva ZV; Bondarenko EI; Kosinova OA; Loktev VB; Shatskiĭ IN; Karpova GG
    Mol Biol (Mosk); 2009; 43(6):1070-6. PubMed ID: 20088384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of translation initiation on hepatitis C virus RNA.
    Nomoto A; Tsukiyama-Kohara K; Kohara M
    Princess Takamatsu Symp; 1995; 25():111-9. PubMed ID: 8875615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold.
    Kieft JS; Zhou K; Jubin R; Murray MG; Lau JY; Doudna JA
    J Mol Biol; 1999 Sep; 292(3):513-29. PubMed ID: 10497018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
    Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B
    FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riboproteomic analysis of polypeptides interacting with the internal ribosome-entry site element of foot-and-mouth disease viral RNA.
    Pacheco A; Reigadas S; Martínez-Salas E
    Proteomics; 2008 Nov; 8(22):4782-90. PubMed ID: 18937254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility.
    Sagan SM; Nasheri N; Luebbert C; Pezacki JP
    Chem Biol; 2010 May; 17(5):515-27. PubMed ID: 20534349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.